LOS ANGELES, Feb. 7, 2017 /PRNewswire/ -- Sovereign Health, a national behavioral health system, is proud to announce that Sovereign Health's Chief Scientific Officer, Veena Kumari, Ph.D., CPsychol, AFBPsS, an internationally renowned authority on cognitive neuroscience, will be presenting "Targeting Abnormal Neural Circuits in Schizophrenia: Effects of Antipsychotics, Cognitive Behavior Therapy, Cognitive Remediation and Mindfulness." The event featuring Dr. Kumari will be held on Feb. 9 from 1:00 p.m. to 2:30 p.m. PST at Pepperdine West Los Angeles Graduate Campus.
Dr. Kumari will discuss the nature, severity and functional consequences of cognitive deficits in schizophrenia; explain structural and functional brain deficits; and identify clinical, cognitive and brain effects of pharmacological and psychological interventions. To RSVP to this event, click here or call 949-304-3362.
Schizophrenia is a severe mental disorder characterized by positive symptoms, negative symptoms and thought disorder. Cognitive dysfunction is a further dimension of impairment that is recognized as a core feature and has clear relevance to real-life outcomes. Cognitive behavioral therapy for psychosis also reduces symptoms, especially in those patients who continue to suffer from one or more distressing symptoms despite remaining medication compliant; it also normalizes brain connectivity within relevant neural networks. Cognitive remediation training is found to enhance cognitive functioning and neural plasticity, particularly in the areas associated with working memory, executive control and emotion processing in people with schizophrenia. Very recently, studies have shown an association between mindfulness and more adaptive emotion regulation in schizophrenia.
As the Chief Scientific Officer, Dr. Kumari represents a significant increase for Sovereign's leadership role in applying novel scientific and technical advances to improve addiction and mental health treatment. Dr. Kumari is an undisputed leader in the psychiatric and neuroscience research fields. She has made significant contributions to the fields of neuroscience of personality and sex differences; cognitive psychopharmacology; information processing deficits in schizophrenia and their pharmacological normalization; neurobiology of cognitive behavioral therapy for psychosis; and neurobiology of violence in schizophrenia and antisocial personality disorder.
Dr. Kumari has published extensively in peer-reviewed journals on measures such as electromyography, electroencephalography, neuropsychology, structural and functional neuroimaging, and genetics. She has over 250 publications in reputable psychology, psychiatry and neuroscience journals, with a current H index of 60 and over 11,000 cumulative citations.
About Sovereign Health
Sovereign Health's mission is to provide a broad spectrum of high-quality behavioral health treatment services for adults and adolescents, including support services for family members. One factor that differentiates Sovereign from other treatment providers has been the company's ability to offer separate mental health and addiction or dual diagnosis treatment programs at its facilities. For more information, visit www.sovhealth.com.
SOURCE Sovereign Health
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article